Advances in enhanced mesenchymal stem cell technologies: innovations and therapeutic applications
Frontiers in Cell and Developmental Biology · 20.07.2026 · 14
DOI: 10.3389/fcell.2026.1868610 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 20.07.2026. Verfasst von Shanshan Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) have attracted considerable attention for clinical translation in regenerative medicine, primarily due to their validated paracrine effects, prominent immunomodulatory properties, and superior multipotent differentiation capabilities. However, the limited homing efficiency and poor post-transplant survival of MSCs severely compromise therapeutic efficacy, thereby giving rise to suboptimal and inconsistent treatment outcomes. To circumvent these critical drawbacks and fully harness the therapeutic potential of MSCs, researchers have incorporated a diverse array of effective strategies, including genetic engineering, preconditioning with cytokines, small molecular compounds or hypoxic stimuli, and scaffold-based culture systems. Given these promising research advances, this review systematically summarizes recent advances in MSC-enhanced therapeutic strategies, and elaborates on their core molecular mechanisms as well as how these mechanisms modulate MSC survival, homing capacity and immunomodulatory efficacy. On this basis, we further analyze the practical applicability of these enhanced MSCs in clinical trials and seek to provide critical insights for the clinical selection of MSC-based enhanced therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
- IND Center, Chongqing Institute of Precision Medicine and Biotechnology Co., Ltd., Chongqing, China.
- The Third Affiliated Hospital of CQMU (FangDa Hospital), Chongqing, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- IND Center, Chongqing Precision Biotech Co., Ltd., Chongqing, China.
- Center for Precision Medicine of Cancer, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Zitieren
APA
Zheng, S., Huang, Y., Yang, X., Mao, X., Hong, J., Tang, M., Yi, P., Xu, Y., & Qian, C. (2026). Advances in enhanced mesenchymal stem cell technologies: innovations and therapeutic applications. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1868610
Vancouver
Zheng S, Huang Y, Yang X, Mao X, Hong J, Tang M, et al. Advances in enhanced mesenchymal stem cell technologies: innovations and therapeutic applications. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1868610
BibTeX
@article{Zheng2026,
author = {Zheng, Shanshan and Huang, Yukang and Yang, Xianli and Mao, Xun and Hong, Juan and Tang, Menglin and Yi, Ping and Xu, Yanmin and Qian, Cheng},
title = {Advances in enhanced mesenchymal stem cell technologies: innovations and therapeutic applications},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1868610}
}
EUVIMED